The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore
- PMID: 15845652
- DOI: 10.1093/carcin/bgi093
The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore
Abstract
Cyclin D1 (CCND1), an intracellular cell-cycle regulatory protein with checkpoint function, can promote cell proliferation or induce growth arrest and apoptosis depending on the cellular context. We hypothesized that the direction of the association between the (CCND1) G870A-polymorphism and breast cancer risk may be modified by dietary and genetic factors influencing the oxidant-antioxidant balance, such as a dietary pattern with a high intake of n-6 fatty acids and a low intake of n-3 fatty acids, or a genetic profile that is deficient in glutathione S-transferases. We tested our hypothesis in a case-control study nested into the Singapore Chinese Health Study, a prospective investigation of diet and cancer in 63,000 Chinese men and women. Genomic DNA collected from 258 incident cases of breast cancer and 670 female cohort controls was examined for CCND1, GSTM1, GSTT1 and GSTP1 genes using fluorogenic 5'-nuclease assay. Unconditional logistic regression models were used to assess the effects with adjustment for potential confounders. All statistical tests were two-sided. The heterozygous CCND1 GA genotype significantly reduced the breast cancer risk in all subjects (OR=0.67, 95% CI 0.45-0.99) when compared with the GG genotype. The association was restricted to women with a high (above median value) intake level of n-6 fatty acids (OR=0.51, 95% CI 0.30-0.87), a low (below median value) intake level of the antagonistic marine n-3 fatty acids (OR=0.54, 95% CI 0.32-0.93) or a total lack of the antioxidative GSTM1 (OR=0.44, 95% CI 0.25-0.80) or GSTT1 genes (OR=0.46, 95% CI 0.24-0.87). The effects were consistently stronger in cases with advanced disease. The AA genotype did not affect breast cancer risk. The results of this study are compatible with the hypothesis that the oxidant-antioxidant balance in cells is an important determinant of the direction of the cyclin D1 effect, leading either to cell proliferation or cell death.
Similar articles
-
The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.Carcinogenesis. 2006 Dec;27(12):2475-82. doi: 10.1093/carcin/bgl116. Epub 2006 Jul 8. Carcinogenesis. 2006. PMID: 16829689
-
Marine n-3 fatty acid intake, glutathione S-transferase polymorphisms and breast cancer risk in post-menopausal Chinese women in Singapore.Carcinogenesis. 2004 Nov;25(11):2143-7. doi: 10.1093/carcin/bgh230. Epub 2004 Jul 15. Carcinogenesis. 2004. PMID: 15256483
-
Association of cyclin D1 genotype with breast cancer risk and survival.Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):91-7. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668481
-
AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.J Cell Biochem. 2019 Oct;120(10):16452-16466. doi: 10.1002/jcb.28800. Epub 2019 Jun 26. J Cell Biochem. 2019. PMID: 31243808
-
Nutritional modulation of the cell cycle and breast cancer.Endocr Relat Cancer. 2004 Dec;11(4):603-22. doi: 10.1677/erc.1.00665. Endocr Relat Cancer. 2004. PMID: 15613442 Review.
Cited by
-
Evaluation of the Role Played by Cyclin D1 as a Diagnostic and Prognostic Marker in the Progression of Oral Carcinogenesis.J Maxillofac Oral Surg. 2018 Sep;17(3):389-395. doi: 10.1007/s12663-018-1087-2. Epub 2018 Jan 29. J Maxillofac Oral Surg. 2018. PMID: 30034160 Free PMC article.
-
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.Breast Cancer Res. 2011 Jan 26;13(1):R10. doi: 10.1186/bcr2817. Breast Cancer Res. 2011. PMID: 21269472 Free PMC article.
-
The Mediterranean Diet and Breast Cancer: A Personalised Approach.Healthcare (Basel). 2019 Sep 9;7(3):104. doi: 10.3390/healthcare7030104. Healthcare (Basel). 2019. PMID: 31505792 Free PMC article. Review.
-
CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.Fam Cancer. 2016 Apr;15(2):201-14. doi: 10.1007/s10689-015-9849-1. Fam Cancer. 2016. PMID: 26545608
-
Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis.Breast Cancer Res. 2007;9(1):201. doi: 10.1186/bcr1628. Breast Cancer Res. 2007. PMID: 17224037 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous